PER 1.23% 8.0¢ percheron therapeutics limited

Ann: Change of Director's Interest Notice - R, page-14

  1. 13,916 Posts.
    lightbulb Created with Sketch. 124
    re: Ann: Change of Director's Interest No... Rare stuff attracts orphan status attracts quicker (smaller trials etc) and longer commercialisation.

    I think it's a good strategy for capital constrained microcap Biotechs.

    Among other things I'm impressed with the longevity of their IP, especially given their two most advanced drugs are mid to late stage.

    If things go to plan they will have well over 10 years exclusivity in the market.



 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
-0.001(1.23%)
Mkt cap ! $72.12M
Open High Low Value Volume
8.2¢ 8.2¢ 8.0¢ $63.52K 777.8K

Buyers (Bids)

No. Vol. Price($)
2 43377 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 97561 1
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.